Increased hepcidin-25 and erythropoietin responsiveness in patients with cardio–renal anemia syndrome
Author:
- 1 November 2010
- journal article
- review article
- Published by Taylor & Francis in Future Cardiology
- Vol. 6 (6) , 769-771
Abstract
Evaluation of: van der Putten K, Jie KE, van den Broek D et al.: Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients. Eur. J. Heart Fail. 12(9), 943–950 (2010). Hepcidin is a key regulator controlling iron intestinal absorption and distribution through the body. The article by van der Putten et al. examined the association between hepcidin-25 and erythropoietin responsiveness and inflammation in erythropoietin-naive, iron-replete patients with chronic heart failure and chronic kidney disease. A cross-sectional observation revealed that serum hepcidin-25 was elevated almost twofold when compared with levels in healthy subjects. Hepcidin-25 was inversely correlated with hemoglobin (r2 = 0.18; p < 0.02), and positively with ferritin (r2 = 0.51; p < 0.01) and transferrin saturation (r2 = 0.14; p < 0.03), while it did not correlate with levels of IL-6 and highly sensitive C-reactive protein. They found that 2-week e...Keywords
This publication has 12 references indexed in Scilit:
- Down-regulation of hepcidin resulting from long-term treatment with an anti–IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman diseaseBlood, 2010
- Erythropoietin regulates intestinal iron absorption in a rat model of chronic renal failureKidney International, 2010
- Hepcidin-25 is a Marker of the Response Rather than Resistance to Exogenous Erythropoietin in Chronic Kidney Disease/Chronic Heart Failure PatientsEuropean Journal of Heart Failure, 2010
- Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rateNephrology Dialysis Transplantation, 2009
- Hepcidin—A Potential Novel Biomarker for Iron Status in Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal diseaseKidney International, 2009
- Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolismNature Chemical Biology, 2007
- Association of Prohepcidin and Hepcidin-25 with Erythropoietin Response and Ferritin in Hemodialysis PatientsAmerican Journal of Nephrology, 2007
- Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balanceJournal of Clinical Investigation, 2007
- Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrationsBlood, 2006